» Articles » PMID: 35247843

Generation of Two Induced Pluripotent Stem Cell (iPSC) Lines (BBANTWi006-A, BBANTWi007-A) from Brugada Syndrome Patients Carrying an SCN5A Mutation

Overview
Journal Stem Cell Res
Publisher Elsevier
Specialty Cell Biology
Date 2022 Mar 5
PMID 35247843
Authors
Affiliations
Soon will be listed here.
Abstract

Brugada syndrome (BrS) is an inherited primary electrical disorder of the heart. 25% of BrS patients carry a mutation in the SCN5A gene, encoding the cardiac specific voltage-gated sodium channel Nav1.5. Here we report two iPSC lines (BBANTWi006-A, BBANTWi007-A) of a brother and a sister carrying an SCN5A mutation (c.4813 + 3_4813 + 6dupGGGT) causing BrS. iPSCs were generated from dermal fibroblasts and reprogrammed with the Cytotune®-iPS 2.0 Sendai Reprogramming Kit (Invitrogen). The generated iPSCs showed a normal karyotype, expressed pluripotency markers, were differentiated into cells of the three germ layers and carried the original genotype.

Citing Articles

The Role of Human-Induced Pluripotent Stem Cells in Studying Cardiac Channelopathies.

Begovic M, Schneider L, Zhou X, Hamdani N, Akin I, El-Battrawy I Int J Mol Sci. 2024; 25(22).

PMID: 39596103 PMC: 11593457. DOI: 10.3390/ijms252212034.


Brugada Syndrome: More than a Monogenic Channelopathy.

Liantonio A, Bertini M, Mele A, Balla C, Dinoi G, Selvatici R Biomedicines. 2023; 11(8).

PMID: 37626795 PMC: 10452102. DOI: 10.3390/biomedicines11082297.


IPSC reprogramming of two patients with spondyloepiphyseal dysplasia congenita (SEDC).

De Kinderen P, Rabaut L, Perik M, Peeters S, Ponsaerts P, Loeys B Stem Cell Res. 2023; 69:103080.

PMID: 36966641 PMC: 10240565. DOI: 10.1016/j.scr.2023.103080.

References
1.
Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D . Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005; 111(5):659-70. DOI: 10.1161/01.CIR.0000152479.54298.51. View

2.
Hong K, Guerchicoff A, Pollevick G, Oliva A, Dumaine R, De Zutter M . Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome. J Mol Cell Cardiol. 2005; 38(4):555-60. DOI: 10.1016/j.yjmcc.2004.10.015. View

3.
Rossenbacker T, Schollen E, Kuiperi C, de Ravel T, Devriendt K, Matthijs G . Unconventional intronic splice site mutation in SCN5A associates with cardiac sodium channelopathy. J Med Genet. 2005; 42(5):e29. PMC: 1736064. DOI: 10.1136/jmg.2004.029058. View

4.
Sieliwonczyk E, Alaerts M, Robyns T, Schepers D, Claes C, Corveleyn A . Clinical characterization of the first Belgian SCN5A founder mutation cohort. Europace. 2020; 23(6):918-927. DOI: 10.1093/europace/euaa305. View